NightShift Radiology, a national on-call teleradiology practice, reports it has passed the two million studies read mark after a decade of service. The milestone reflects the stability of NightShift Radiology in the ever-changing landscape of the teleradiology industry, the company said.
NightShift Radiology, a national on-call teleradiology practice, reports it has passed the two million studies read mark after a decade of service. The milestone reflects the stability of NightShift Radiology in the ever-changing landscape of the teleradiology industry, the company said.
“This achievement not only commemorates NightShift Radiology’s ability to consistently deliver high-quality readings efficiently and effectively, but also our longevity in the marketplace,” said Dr. Michael Myers, cofounder of NightShift. “It’s important for current and future clients to understand that not only do we have an impressive track record, we’re here for the long haul. NightShift’s radiologists can be depended upon to support our clients while protecting their business interests. We want to be considered a valuable asset, not a threat to their practice.”
NightShift Radiology’s network offers on-call teleradiology services and support to radiology practices nationwide.
The majority of NightShift’s radiologists are fellowship-trained or have advanced Certificate of Added Qualification (CAQ) training. In addition, all radiologists are U.S.-based and employed full-time by NightShift, which enables them to be scheduled to assignments for five to seven days in most instances. Each radiologist can be reached directly via phone or fax.
To ensure ongoing refinement and enhancement of services, NightShift’s processes are transparent and feature comprehensive quality assurance/quality improvement programs. In addition to standard service delivery systems, NightWatch, the company’s proprietary web-based tool, provides real-time access for case review and printing of radiology and administrative reports on demand.
During most of the company’s 10 years in business, NightShift cofounder Dr. Eric Trefelner was a columnist for Diagnostic Imaging.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.